Suki integrates with major EHR systems, recording conversations and notes, and using the data to complete paperwork automatically. Suki states that by using this system, time spent taking notes can be reduced by around 75% which converts into a 12% increase in time spent with patients. Providing software free of charge also acts as a great way to get product feedback and act as a marketing tactic should healthcare professionals enjoy using their technology.

The company raised series C funding in 2021 that has funded a number of strategic investments that will ultimately lead to an expansion of its customer base through new partnerships with health systems and medical groups. 2022 saw Suki increase its uses by 7x, all whilst implementing updates and upgrades to its products. In 2023, it achieved greater industry recognition with the hiring of Dr Stephen Kahane to its board of directors, known for advising and investing in successful MedTech outfits such as Datavant and Signify Health.